Chronic diarrhoea is a common condition, resulting from a number of different disorders. Bile acid diarrhoea, occurring in about a third of these patients, is often undiagnosed. We hypothesised that a positive diagnosis of bile acid diarrhoea would reduce the need for subsequent investigations for alternative diagnoses. METHODS: Patients previously recruited to a study of chronic diarrhoea who had selenium homocholic acid taurine (SeHCAT) testing and subsequent follow-up at our institution were identified. In a retrospective analysis, the numbers of defined investigations undertaken from the first 3 months after SeHCAT in the following 5 years were compared. RESULTS: 90 patients were identified with primary bile acid diarrhoea (SeHCAT retention <15%, n=36) or idiopathic diarrhoea (SeHCAT retention >15%, n=54). Follow-up had been performed on 29 and 39 subjects, respectively, with no differences in previous investigations or the last contact date. In the follow-up period, the proportions of these patients who had undergone endoscopic procedures (gastroscopy, colonoscopy and sigmoidoscopy) were the same. However, there was a higher proportion of patients in the SeHCAT-negative group who had other investigations, including imaging, physiological tests and blood tests (p=0.037). The use of cross-sectional imaging was significantly higher in this group (p=0.015) with greater proportions having CT (0.44 vs 0.10) and MRI (0.26 vs 0.07). Ultrasound use and the number of blood tests were higher in the SeHCAT-negative group whereas the SeHCAT-positive group attended more clinic appointments (p=0.013). CONCLUSION: A positive diagnosis of bile acid diarrhoea, made by a SeHCAT test, resulted in reduced use of diagnostic investigations over the subsequent 5 years.
Chronic diarrhoea is a common condition, resulting from a number of different disorders. Bile acid diarrhoea, occurring in about a third of these patients, is often undiagnosed. We hypothesised that a positive diagnosis of bile acid diarrhoea would reduce the need for subsequent investigations for alternative diagnoses. METHODS:Patients previously recruited to a study of chronic diarrhoea who had selenium homocholic acid taurine (SeHCAT) testing and subsequent follow-up at our institution were identified. In a retrospective analysis, the numbers of defined investigations undertaken from the first 3 months after SeHCAT in the following 5 years were compared. RESULTS: 90 patients were identified with primary bile acid diarrhoea (SeHCAT retention <15%, n=36) or idiopathic diarrhoea (SeHCAT retention >15%, n=54). Follow-up had been performed on 29 and 39 subjects, respectively, with no differences in previous investigations or the last contact date. In the follow-up period, the proportions of these patients who had undergone endoscopic procedures (gastroscopy, colonoscopy and sigmoidoscopy) were the same. However, there was a higher proportion of patients in the SeHCAT-negative group who had other investigations, including imaging, physiological tests and blood tests (p=0.037). The use of cross-sectional imaging was significantly higher in this group (p=0.015) with greater proportions having CT (0.44 vs 0.10) and MRI (0.26 vs 0.07). Ultrasound use and the number of blood tests were higher in the SeHCAT-negative group whereas the SeHCAT-positive group attended more clinic appointments (p=0.013). CONCLUSION: A positive diagnosis of bile acid diarrhoea, made by a SeHCAT test, resulted in reduced use of diagnostic investigations over the subsequent 5 years.
Entities:
Keywords:
chronic diarrhoea; diarrhoeal disease; health service research; imaging; nuclear medicine
Authors: P D Thomas; A Forbes; J Green; P Howdle; R Long; R Playford; M Sheridan; R Stevens; R Valori; J Walters; G M Addison; P Hill; G Brydon Journal: Gut Date: 2003-07 Impact factor: 23.059
Authors: Matthew Kurien; Kate E Evans; John S Leeds; Andy D Hopper; Andrew Harris; David S Sanders Journal: Scand J Gastroenterol Date: 2011-04-15 Impact factor: 2.423
Authors: Imran Aziz; Saqib Mumtaz; Hassan Bholah; Fahmid U Chowdhury; David S Sanders; Alexander C Ford Journal: Clin Gastroenterol Hepatol Date: 2015-03-10 Impact factor: 11.382
Authors: A C Ford; P Bercik; D G Morgan; C Bolino; M I Pintos-Sanchez; P Moayyedi Journal: Aliment Pharmacol Ther Date: 2013-12-05 Impact factor: 8.171
Authors: Nelson Valentin; Michael Camilleri; Osama Altayar; Priya Vijayvargiya; Andres Acosta; Alfred D Nelson; M Hassan Murad Journal: Gut Date: 2015-09-07 Impact factor: 23.059
Authors: Ayman Bannaga; Lawrence Kelman; Michelle O'Connor; Claire Pitchford; Julian R F Walters; Ramesh P Arasaradnam Journal: BMJ Open Gastroenterol Date: 2017-01-19
Authors: Priya Vijayvargiya; Daniel Gonzalez Izundegui; Gerardo Calderon; Sarah Tawfic; Sarah Batbold; Michael Camilleri Journal: Am J Gastroenterol Date: 2020-07 Impact factor: 10.864
Authors: Ramesh P Arasaradnam; Steven Brown; Alastair Forbes; Mark R Fox; Pali Hungin; Lawrence Kelman; Giles Major; Michelle O'Connor; Dave S Sanders; Rakesh Sinha; Stephen Charles Smith; Paul Thomas; Julian R F Walters Journal: Gut Date: 2018-04-13 Impact factor: 23.059
Authors: Virginia Flores; Helena Martínez-Lozano; Federico Bighelli; Javier Orcajo; Javier García-Lledó; Juan Carlos Alonso-Farto; Luis Menchén Journal: BMC Gastroenterol Date: 2021-02-09 Impact factor: 3.067